TSS
OGEN icon

Two Sigma Securities’s Oragenics OGEN Stock Holding History

Two Sigma Securities’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,343
Closed -$11.4K – 2176
2026
Q1 		$11.4K Buy
+20,343
New +$16.1K ﹤0.01% 1451
2025
Q2 		– Sell
-837
Closed -$5.27K – 1916
2025
Q1 		$5.27K Buy
837
+271
+48% +$2.34K ﹤0.01% 1299
2024
Q4 		$6.27K Buy
+566
New +$5.8K ﹤0.01% 1472
2023
Q1 		– Sell
-13
Closed -$2.54K – 3082
2022
Q4 		$2.54K Sell
13
-3
-19% -$1.06K ﹤0.01% 2498
2022
Q3 		$7K Buy
+16
New +$9.35K ﹤0.01% 2447
2022
Q2 		– Sell
-17
Closed -$10K – 2672
2022
Q1 		$10K Sell
17
-21
-55% -$15.4K ﹤0.01% 2044
2021
Q4 		$31K Buy
+38
New +$38.5K ﹤0.01% 1351
2021
Q2 		– Sell
-6
Closed -$10K – 1643
2021
Q1 		$10K Sell
6
-7
-54% -$12.7K ﹤0.01% 788
2020
Q4 		$11K Buy
+13
New +$11.4K ﹤0.01% 1623
2019
Q3 		– Sell
-20
Closed -$18K – 2335
2019
Q2 		$18K Buy
+20
New +$18.4K ﹤0.01% 1957
2019
Q1 		– Sell
-7
Closed -$11K – 2258
2018
Q4 		$11K Sell
7
-21
-75% -$41.2K ﹤0.01% 2011
2018
Q3 		$58K Buy
+28
New +$32.3K ﹤0.01% 2353

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Two Sigma Securities's OGEN Position: Q2 2026 in Review

Two Sigma Securities sold out of Oragenics (OGEN) in Q2 2026, closing a stake of 20,343 shares — an estimated $11.4K sold.

Two Sigma Securities first reported a position in OGEN in Q3 2018 and held it in 12 quarters. The position peaked at $58K in Q3 2018. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • Two Sigma Securities reported no remaining Oragenics position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 20,343 Oragenics shares in Q2 2026, an estimated $11.4K.
  • Two Sigma Securities first reported a position in Oragenics in Q3 2018 and held it in 12 quarters.
  • Two Sigma Securities's Oragenics position peaked at $58K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.